September 8, 2017 — ClearFlow Inc. announced recently that positive clinical trial results were presented at the International Coronary Congress (ICC) 2017 annual meeting, Aug. 18-20 in New York City. The findings were presented by the study principal investigator Yvon Baribeau, M.D., FACS, of Catholic Medical Center in Manchester, N.H., in a presentation titled “Active Clearance of Chest Drains Reduces Retained Blood and ICU Resources after Off-Pump Coronary Artery Bypass Surgery.”

Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular scaffold as of Sept. 14, 2017. The company said low sales of the bioabsorbable stent led to the decision to stop offering the product.  

September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to market their XR-29 DoseCheck solution.

The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to late-breaking research presented today in a Hot Line Late-breaking Clinical Trial session at he European Society of Cardiology (ESC) Congress. The results of the The Left Atrial Appendage Closure by Surgery (LAACS) study suggest that LAA closure should be routinely added to open heart surgery.
Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research from the DETO2X-AMI Study presented in a Hot Line session at the European Society of Cardiology (ESC) Congress and published in the New England Journal of Medicine (NEJM).
PURE study may cause revision of fat intake guidelines for cardiology.

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of global dietary guidelines in light of new late-breaking data presented from the Prospective Urban-Rural Epidemiology (PURE) on fat intake and cardiovascular risk and mortality. The study was presented at ESC and also published in the Lancet.

In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U.S. Food and Drug Administration (FDA)-cleared high sensitive Elecsys Troponin T Gen 5 blood test (Troponin T Gen 5 or TnT Gen 5) to aid in the diagnosis of heart attacks.  The new nine-minute test offers faster answers clinicians can use when diagnosing heart attack.

Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo System is an intra-aortic filter device that deflects embolic material arising during TAVR away from the brain.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now